Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors

Gene Therapy

Volumn 12, Issue 17, 2005, Pages 1313-1323

  Rehman, K K ^a   Wang, Z ^a   Bottino, R ^a   Balamurugan, A N ^a   Trucco, M ^a   Li, J ^a   Xiao, X ^a   Robbins, P D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adeno associated viral vector; Islet transplantation and type 1 diabetes

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GLUCOSE; INSULIN; PARVOVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; GENE TRANSFER; GENETIC TRANSDUCTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RODENT; SEROTYPE; VIRUS MORPHOLOGY;

ANIMALS; COMBINED MODALITY THERAPY; DEPENDOVIRUS; DIABETES MELLITUS, TYPE 1; DNA; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GLUCOSE TOLERANCE TEST; GREEN FLUORESCENT PROTEINS; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; PARVOVIRIDAE INFECTIONS; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSGENES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA; MURINAE; PARVOVIRUS; RODENTIA;

EID: 30644470444     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302530     Document Type: Article

References (48)

1. Atkinson MA, Madaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-1436.
2. Loweth AC et al. Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation. Diabetes 1998; 47: 727-732.
3. Pakala SV, Chivetta M, Kelly CB, Katz JD. In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med 1999; 189: 1053-1062.
4. Herrera PL, Harlan DM, Vassalli P. A mouse CD8T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: Possible role of membrane TNF. Proc Natl Acad Sci USA 2000; 97: 279-284.
5. Kreuwel HT et al. Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. J Immunol 1999; 163: 4335-4341.
6. Shapiro AM et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
7. Hirshberg B et al. State of the art: Islet transplantation for the cure of type 1 diabetes mellitus. Rev Endocr Metab Disord 2003; 4: 381-389.
8. Gagha JL, Harlan DM. Transplantation tolerance. Curr Dir Autoimmun 2001; 4: 283-307.
9. Harlan DM, Kirk AD. The future of organ and tissue transplantation: Can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection? JAMA 1999; 282: 1076-1082.
10. Paty BW, Harmon JS, Marsh CL, Robertson RP. Inhibitory effects of immunosuppressive drugs on insulin secretion from HIT-T15 cells and Wistar rat islets. Transplantation 2002; 73: 353-357.
11. Gallichan WS et al. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 1998; 9: 2717-2726.
12. Deng S et al. IL-10 and TGF-beta gene transfer to rodent islets: Effect on xenogeneic islet graft survival in naive and B-cell-deficient mice. Transplant Proc 1997; 29: 2207-2208.
13. Bertera S et al. Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes 2003; 52: 387-393.
14. Gainer AL et al. Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival. Transplantation 1997; 63: 1017-1021.
15. Contreras JL et al. Cytoprotection of pancreatic islets before and soon after transplantation by gene transfer of the anti-apoptosic Bcl-2 gene. Transplantation 2001; 71: 1015-1023.
16. Tobiasch E, Gunther L, Bach FH. Heme oxygenase-1 protects pancreatic beta cells from apoptosis caused by various stimuli. J Invest Med 2001; 49: 566-571.
17. Csete ME et al. Adenoviral-mediated gene transfer to pancreatic islets does not alter islet function. Transplant Proc 1994; 26: 756-757.
18. Csete ME et al. Efficient gene transfer to pancreatic islets mediated by adenoviral vectors. Transplantation 1995; 59: 263-268.
19. Giannoukakis N et al. Infection of intact human islets by a lentiviral vector. Gene Therapy 1999; 6: 1545-1551.
20. Ju Q et al. Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia 1998; 41: 736-739.
21. Curran MA et al. Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors1. Transplantation 2002; 74: 299-306.
22. Bottino R, Lemarchand P, Trucco M, Giannoukakis N. Gene- and cell-based therapeutics for type I diabetes mellitus. Gene Therapy 2003; 10: 875-889.
23. Flotte T et al. Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors. Diabetes 2001; 50: 515-520.
24. Kapturczak M et al. Transduction of human and mouse pancreatic islet cells using a bicistronic recombinant adeno-associated viral vector. Mol Ther: J Am Soc Gene Ther 2002; 5: 154-160.
25. Yang YW, Kotin RM. Glucose-responsive gene delivery in pancreatic islet cells via recombinant adeno-associated viral vectors. Pharmaceut Res 2000; 17: 1056-1061.
26. Beans KI, Giraud C. Biology of adeno-associated virus. Curr Top Microbiol Immunol 1996; 218: 1-23.
27. Afione SA et al. Delayed expression of adeno-associated virus vector DNA. Intervirology 1999; 42: 213-220.
28. Ferrari FK, Samulski T, Shenk T, Samulski RJ. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J Virol 1996; 70: 3227-3234.
29. Alexander AM et al. Indoleamine 2,3-dioxygenase expression in transplanted NOD islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 2002; 51: 356-365.
30. Barrou B et al. Prolonged islet allograft survival by adenovirus-mediated transfer of sICAM-1/Ig immunoadhesin gene. Hum Gene Ther 2002; 13: 1441-1450.
31. Feng S et al. Prolonged xenograft survival of islets infected with small doses of adenovirus expressing CTLA4Ig. Transplantation 1999; 67: 1607-1613.
32. Sutherland RM et al. Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts. Transplantation 2000; 69: 1806-1812.
33. Wang Z et al. Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Therapy 2003; 10: 2105-2111.
34. Giannoukakis N, Trucco M. Current status and prospects for gene and cell therapeutics for type 1 diabetes mellitus. Rev Endocr Metab Disord 2003; 4: 369-380.
35. Loiler SA et al. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Therapy 2003; 10: 1551-1558.
36. Zhang YC et al. Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity. Gene Therapy 2004; 11: 233-240.
37. Giannoukakis N, Trucco M. Autoimmunity and gene therapy: The nemesis of autoimmunity. Gene Therapy 2004; 11: 231-232.
38. Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224-2232.
39. Gao GP et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854-11859.
40. Rabinowitz JE et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791-801.
41. Rutledge EA, Halbert CL, Russell DW. Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998; 72: 309-319.
42. Snyder R, Xiao X, Samulski RJ. Production of recombinant adeno-asociated viral vectors. In: Smith D (ed). Current Protocols in Human Genetics. John Wiley & Sons Ltd: New York, 1996, pp 12.1.1-12.2.23.
43. Rehman KK et al. Protection of islets by in situ peptide-mediated transduction of the Ikappa B kinase inhibitor Nemo-binding domain peptide. J Biol Chem 2003; 278: 9862-9868.
44. Bottino R et al. Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes 2002; 51: 2561-2567.
45. Lorenzo A, Razzaboni B, Weir GC, Yankner BA. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994; 368: 756-760.
46. Like AA, Appel MC, Williams RM, Rossini AA. Streptozotocin-induced pancreatic insulitis in mice. Morphologic and physiologic studies. Lab Invest 1978; 38: 470-486.
47. Hogan B, Beddington R, Costantini F, Lacy E. Avertin, anesthetic. In: Inglis J, Cuddihy J (eds). Manipulating the Mouse Embryo, A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press: ME, 1994, pp 416.
48. Tatarkiewicz K et al. Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets. Transplantation 1999; 67: 665-671.